Hematological parameters | Weekly dose cisplatin (mean dose: 30 mg/m2) (n = 15) | Every 3-week dose cisplatin (mean dose: 100 mg/m2) (n = 15) | Control | ANOVA (p value) | ||||
---|---|---|---|---|---|---|---|---|
Pre chemotherapy | Post chemotherapy | Change (%) | Pre chemotherapy | Post chemotherapy | Change (%) | |||
WBC count | 8.6 ± 2.5 a | 6.3 ± 1.6 a | − 26.6 | 6.8 ± 1.9 | 5.7 ± 1.1 | − 16.5 | 5.5 ± 1.6 | *** |
Neutrophil count | 5.8 ± 2.4a2 | 3.5 ± 1.9a2 | − 40.2 | 4.3 ± 1.9 | 3.48 ± 1.3 | − 19.6 | 3.4 ± 1.2 | ** (.0018) |
Lymphocyte count | 2.2 ± 1.1 | 1.7 ± 0.7 | − 21.4 | 1.5 ± 0.6b | 1.2 ± 0.6b | − 23.3 | 1.8 ± 0.6 | * (0.0115) |
RBC count | 4.8 ± 0.8 a1 | 3.91 ± 0.5a1 | − 17.9 | 4.5 ± 0.8 | 3.9 ± 0.5 | − 12.1 | 4.4 ± 0.5x | ** (.0017) |
Platelet count | 222.6 ± 44.4y | 166 ± 44.2y,x | − 25.4 | 159. ± 24.1 | 136.1 ± 12.4z | − 14.8 | 222.6 ± 44.4x,z | *** |